Diet quality of children post‐liver transplantation does not differ from healthy children

• Published in: Pediatric transplantation Vol. 21; no. 6
• Main Authors: Alzaben, Abeer S., MacDonald, Krista, Robert, Cheri, Haqq, Andrea, Gilmour, Susan M., Yap, Jason, Mager, Diana R.
• Format: Journal Article
• Language: English
• Published: Denmark Wiley Subscription Services, Inc 01-09-2017
• Subjects: Adolescent; Adolescents; Case-Control Studies; Child; Child, Preschool; Children; Diet; diet quality; Dietary intake; Female; Fructose; Humans; Immunosuppressive agents; Liver Transplantation; Liver transplants; Male; Nutrition Assessment; Nutritional Status; Pilot Projects; Postoperative Period; Prospective Studies; Sugar; Transplantation; Transplants & implants; Vitamin B12; liver transplantation; dietary intake; diet quality
• ISSN: 1397-3142; 1399-3046
• DOI: 10.1111/petr.12944

Little has been studied regarding the diets of children following LTX. The study aim was to assess and compare dietary intake and DQ of healthy children and children post‐LTX. Children and adolescents (2‐18 years) post‐LTX (n=27) and healthy children (n=28) were studied. Anthropometric and demographic data and two 24‐hour recalls (one weekend; one weekday) were collected. Intake of added sugar, HFCS, fructose, GI, and GL was calculated. DQ was measured using three validated DQ indices: the HEI‐C, the DGI‐CA, and the DQI‐I. Although no differences in weight‐for‐age z‐scores were observed between groups, children post‐LTX had lower height‐for‐age z‐scores than healthy children (P<.01). With the exception of vitamin B12, no significant differences in energy and macronutrient (protein, carbohydrate, and fat), added sugar, HFCS, fructose, GI, GL, and micronutrient intakes and DQ indices (HEI‐C, DGI‐CA, and DQI‐I) between groups were observed (P>.05). The majority of children in both groups (>40%) had low DQ scores. No significant interrelationships between dietary intake, anthropometric, and demographic were found (P>.05). Both healthy and children post‐LTX consume diets with poor DQ. This has implications for risk of obesity and metabolic dysregulation, particularly in transplant populations on immunosuppressive therapies.